Accro Bioscience and Fosun Pharma ink agreement for TYK2/JAK1 Inhibitor in Greater China
Accro will retain global rights to develop, manufacture, and commercialize AC-201 (excluding Chinese Mainland, Hong Kong SAR, and Macau SAR)
Accro will retain global rights to develop, manufacture, and commercialize AC-201 (excluding Chinese Mainland, Hong Kong SAR, and Macau SAR)
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
This strategic investment strengthens Cohance's integrated oligonucleotide platform
This will be Aster’s fifth hospital in Bengaluru
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
Subscribe To Our Newsletter & Stay Updated